{
     "PMID": "20048438",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100429",
     "LR": "20131121",
     "IS": "0917-5857 (Print) 0917-5857 (Linking)",
     "VI": "20",
     "IP": "1",
     "DP": "2010 Jan",
     "TI": "[Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists].",
     "PG": "83-8",
     "LID": "CliCa10018388 [doi]",
     "AB": "Voltage-dependent Ca(2+) channels have been divided into at least 5 types (L-, N-, T-, P-, and Q-type). L/N-type Ca(2+) channel blocker cilnidipine could reduce the size of cerebral infarction in the rat focal brain ischemia. L-type Ca(2+) channel blocker amlodipine reduced cerebral edema and inhibit neuronal cell death. N-type Ca(2+) channel blocker omega-conotoxin reduce the size of cerebral infarction and inhibit delayed neuronal cell death in hippocampal CA1 area. It is suggested that calcium antagonist has neuroprotective effect.",
     "FAU": [
          "Ito, Yasuo",
          "Araki, Nobuo"
     ],
     "AU": [
          "Ito Y",
          "Araki N"
     ],
     "AD": "Department of Neurology, Faculty of Medicine, Saitama Medical University, Japan.",
     "LA": [
          "jpn"
     ],
     "PT": [
          "English Abstract",
          "Journal Article",
          "Review"
     ],
     "PL": "Japan",
     "TA": "Clin Calcium",
     "JT": "Clinical calcium",
     "JID": "9433326",
     "RN": [
          "0 (Calcium Channel Blockers)",
          "0 (Calcium Channels, L-Type)",
          "0 (Calcium Channels, N-Type)",
          "0 (Dihydropyridines)",
          "0 (Neuroprotective Agents)",
          "0 (omega-Conotoxins)",
          "1J444QC288 (Amlodipine)",
          "97T5AZ1JIP (cilnidipine)"
     ],
     "SB": "IM",
     "MH": [
          "Amlodipine/*pharmacology/*therapeutic use",
          "Animals",
          "Brain Edema/*drug therapy",
          "Calcium Channel Blockers/*pharmacology/*therapeutic use",
          "Calcium Channels, L-Type",
          "Calcium Channels, N-Type",
          "Cell Death/drug effects",
          "Cerebral Infarction/*drug therapy",
          "Dihydropyridines/*pharmacology/*therapeutic use",
          "Hippocampus/cytology",
          "Humans",
          "Neurons/pathology",
          "*Neuroprotective Agents",
          "Rats",
          "omega-Conotoxins/*pharmacology/*therapeutic use"
     ],
     "RF": "14",
     "EDAT": "2010/01/06 06:00",
     "MHDA": "2010/04/30 06:00",
     "CRDT": [
          "2010/01/06 06:00"
     ],
     "PHST": [
          "2010/01/06 06:00 [entrez]",
          "2010/01/06 06:00 [pubmed]",
          "2010/04/30 06:00 [medline]"
     ],
     "AID": [
          "10018388 [pii]",
          "CliCa10018388 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Clin Calcium. 2010 Jan;20(1):83-8. doi: CliCa10018388.",
     "term": "hippocampus"
}